Please assess the completion status of the following clinical trial:

Trial Title: GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Adults with unilateral or bilateral Geographic Atrophy (GA) due to Age-related Macular Degeneration (AMD)~2. BCVA of 40 letters or better using ETDRS charts~Exclusion Criteria:~1. Evidence or history of neovascular Age-related Macular Degeneration (AMD) or diabetic retinopathy~2. Significant ocular or non-ocular disease that would impact the subject's ability to participate in the study~3. Participation in another research study involving an investigational product within the previous 4 weeks or 5 half-lives whichever is longer from the screening/baseline OR received a gene/cell therapy at any time previously

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).